Results | A total of 1141 donor corneas were used for 1237 transplantations (714 DMEKs, 316 PKs, 100 DALKs, 74 Descemet stripping automated endothelial keratoplasties, and 33 others [7 Boston keratoprostheses and 26 tectonic corneoscleral patches]) in 951 patients (475 women, 476 men; mean [SD] age, 64.3 [17.4] years). Both DALK and DMEK were combined in 72 cases (75.0%), DMEK and tectonic corneoscleral patches were combined in 13 cases (13.5%), mini-PK (eccentric PKs, diameter ≤5 mm) and small DMEKs were combined in 5 cases (5.2%), Descemet stripping automated endothelial keratoplasty and tectonic corneoscleral patches were combined in 5 cases (5.2%), and Boston keratoprosthesis was combined with DMEK in 1 case (1.1%). Split-cornea transplantation was intended but not possible in 5 cases owing to conversion of DALK to PK (2 cases) or unexpected intraoperative events during DMEK surgery (3 cases), including complicated unfolding of the donor membrane. A total of 15.1% of corneal grafts could be performed as split-cornea transplantation, and a total of 96 donor buttons (7.8% [95% CI, 6.2%-9.4%]) could be saved. Discussion | Our data show that indications and referrals for DMEK exceed those for DALK by far (714 vs 100, respectively). Only 15.1% of corneal grafts could be performed as splitcornea transplantation, resulting in 96 donor corneas being saved (7.8%). This asymmetric distribution suggests the need for scheduling DMEK and DALK recipients. Novel techniques with the potential to increase the availability of donor tissue, eg, using hemi-DMEKs (splitting 1 endothelial graft into 2 halfmoon-shaped grafts), 3, 6 should be considered. 
Sequential Optical Coherence Tomographic Angiography for Diagnosis and Treatment of Choroidal Neovascularization in Multifocal Choroiditis
Accurate diagnosis of choroidal neovascularization (CNV) is critical to ensure timely anti-vascular endothelial growth factor therapy and preclude loss of visual acuity. Dye-based angiography is the gold standard for CNV diagnosis; however, it is in-Report of a Case | A woman in her early 40s presented with acute vision loss in her left eye of 2 days' duration. Her medical and travel histories were noncontributory. She was a glaucoma suspect based on optic nerve appearance. Best-corrected visual acuity was 20/20 OD and 20/40 OS. The right eye was normal with the exception of mild peripapillary atrophy and a cupdisc ratio of 0.7. In the left eye, there was mild 1+ cellular reaction in the anterior chamber and vitreous. There was a mildly elevated, hypopigmented deep chorioretinal lesion in the left fovea ( Figure 1A ) without associated fluid, hemorrhage, or exudate and scattered, small punctate and linear yellow deep choroidal lesions peripherally. Fluorescein angiography demonstrated early hyperfluorescence and late staining of the chorioretinal spots and staining of peripheral retinal veins ( Figure 1B -D). Indocyanine green angiography revealed peripheral hypofluorescent spots and a pinpoint dot of late hyperfluorescence in the fovea ( Figure 1E and F). Conventional spectral-domain OCT (Cirrus; Carl Zeiss Meditec) demonstrated an elevated foveal lesion beneath the retinal pigment epithelium with thickening and loss of distinct margins of the overlying ellipsoid and interdigitation bands but no fluid ( Figure 2A ). Multifocal choroiditis was diagnosed based on clinical and angiographic findings. Systemic testing results including the Venereal Disease Research Laboratory test, lysozyme, angiotensin-converting enzyme, purified protein derivative, and chest radiography were normal. The foveal lesion was clinically suspect for CNV; however, this was not conclusive after dye-based angiography and spectral-domain OCT. Retinal vascular imaging with the prototype AngioVue OCTA software on the commercially available Avanti spectral-domain OCT device (Optovue) was performed. The 3 × 3-mm OCT angiogram demonstrated a lacy network of vessels in the outer retina scan, confirming the presence of CNV as this location is devoid of vessels in healthy eyes ( Figure 2B ). One week after treatment with intravitreal bevacizumab (1.25 mg/0.05 mL), OCTA revealed reduction in size and density of the CNV complex ( Figure 2E and F). Sequential OCTA following the first ( Figure 2G and H) and second ( Figure 2I and J) treatments with bevacizumab revealed progressive, nearcomplete resolution of flow through the CNV. The lesion appeared inactive clinically without leakage on fluorescein angiography after the second treatment with bevacizumab. The 
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Facial Ulcers and Restrictive Strabismus From Delayed Periorbital Granuloma After Poly-L-Lactic Acid Injection
Complications of injectable fillers are uncommon but potentially devastating. Most adverse events occur soon after injection and are mild, including redness, itching, blanching, and nodule formation. Report of a Case | A 49-year-old woman presented to the oculoplastics clinic with healed ulcers of the lower lip and nasal dorsum and a nonhealing ulcer of the left lateral infraorbital area. She reported several years of facial ulcers described as "scratches" developing over weeks to months into red, indurated, tender ulcers that finally crusted and healed. Prior to presenting to our clinic, she had undergone a punch biopsy of the lip lesion and debridement of the nasal ulcer in separate procedures at outside institutions. The pathology department found granulomatous inflammation of unclear etiology. Our evaluation included consultations with the dermatology, otolaryngology, rheumatology, infectious diseases, gastroenterology, and psychiatry departments during which numerous diagnoses were considered, including scleroderma, granulomatosis with polyangiitis, polymyositisscleromyositis overlap syndrome, leprosy, and factitious disease. Our patient denied any history of facial surgery or exposures to foreign material or fillers. The patient's review of systems was positive for dry mouth, Raynaud phenomenon, morning joint pain, mild hand and ankle swelling, and dysphagia. Maxillofacial computed tomography identified a nasal septal perforation, saddle nose deformity, clear paranasal sinuses, and the left infraorbital soft-tissue defect. Laboratory study results included positive findings for antinuclear antibodies (titer, 1:360; nuclear and cytoplasmic staining), mildly elevated angiotensin-converting enzyme level (78 U/L [to convert to nanokatals per liter, multiply by 16.667]), and mildly decreased C4 complement level. All other laboratory results were normal, including anti-proteinase 3, antimyeloperoxidase, anti-Scl-70, human immunodeficiency virus, antiphospholipid, C3 complement, anticitrullinated protein, human leukocyte antigen B27, T-SPOT.TB test for tuberculosis, syphilis, erythrocyte sedimentation rate, and C-reactive protein. Biopsies of the ulcer base showed foreign-body granulomas and scant polarizable material of uncertain diagnostic significance. Cultures were negative for infectious causes, including leishmaniasis and acidfast bacteria. The patient began treatment with oral prednisone and methotrexate to control inflammation.
Several months later, the patient developed diplopia, a sense of fullness below the left eye, and extrusion of white fibrous material from the ulcer base. Repeated examination found restriction of the left eye into a hypotropic and exotropic position and a full-thickness defect through the lateral lower eyelid, exposing conjunctiva and bony orbital rim (Figure 1) . Magnetic reso- A, The saddle nose deformity (black arrowhead) and infraorbital ulcer (white arrowhead) seen at onset of the diplopia. B, Several months later after the diplopia had stabilized and with the patient's daily dressings in place.
